Case Study Of Cellulitis

1663 Words7 Pages
outcome measured the proportion of patients that had a repeat of cellulitis during the drug phase and follow-up phase (Thomas et al., 2013). The results of this experiment showed some interesting information. In the end 136 patients were put into the penicillin group and 138 patients were put into the placebo group. From these patients 15 (5%) took back consent or couldn’t be found, 11 died (4%) and 206 (75%) were put into a secondary care (Thomas et al., 2013). In total 247 (90%) of the patients did the minimum of 18 months of follow-ups and 214 (78%) said that they took at least 75% of the tablets between the two groups (Thomas et al., 2013). During the trial, the primary outcome saw that it took a median of about 626 days in the…show more content…
Antoher group was given clarithromycin and hydroxychloroquine mix 500 mg and 200 mg respectively twice daily (Berende et al., 2016). And the other patients got placebos twice daily (Berende et al., 2016). Everyone was blindly assigned. At the end of the study 205 patients (73.2%) reported a minimum of one adverse effect, like diarrhea or nausea (Table 2) (Berende et al., 2016). Nine people had a serious adverse effect and 19 had a bad enough side effect that they discontinued with the study (Table 2) (Berende et al., 2016). In the end though most of the patients made it throughout the whole study. To measure results the researchers used a 36-question questionnaire at the beginning at the end of the treatment of the 14 weeks, at 26 weeks, at 40 weeks, and finally 52 weeks after treatment (Berende et al., 2016). From the results 252(90%) of the patients completed the study. 76 out of 86 for the doxycycline, 64 out of 96 for the clarithromycin-hydroxychloroquine and 92 out of 98 patients finished from the placebo group (Berende et al., 2016). At the end of the study the results showed some interesting results. By looking at the questionnaire mean all the patients quality of life increased from the original of 31.8 to 36.4 at the end of the treatment. Even though the scores were higher at the end of the treatment there was no significant difference in any of the groups that were studied
Open Document